The global Pharma Sustained Release Agent market was valued at million in 2024 and is projected to reach US$ million by 2031, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma Sustained Release Agent manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Pharma Sustained Release Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Sustained Release Agent. This report contains market size and forecasts of Pharma Sustained Release Agent in global, including the following market information:
Global Pharma Sustained Release Agent market revenue, 2020-2025, 2026-2031, ($ millions)
Global Pharma Sustained Release Agent market sales, 2020-2025, 2026-2031, (Kiloton)
Global top five Pharma Sustained Release Agent companies in 2024 (%)
Total Market by Segment:
Global Pharma Sustained Release Agent market, by Type, 2020-2025, 2026-2031 ($ millions) & (Kiloton)
Global Pharma Sustained Release Agent market segment percentages, by Type, 2024 (%)
Gelatin
Polymers
Minerals
Sugars
Chitosan
Global Pharma Sustained Release Agent market, by Application, 2020-2025, 2026-2031 ($ Millions) & (Kiloton)
Global Pharma Sustained Release Agent market segment percentages, by Application, 2024 (%)
Pharmaceutical
Health Care
Others
Global Pharma Sustained Release Agent market, by region and country, 2020-2025, 2026-2031 ($ millions) & (Kiloton)
Global Pharma Sustained Release Agent market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma Sustained Release Agent revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Pharma Sustained Release Agent revenues share in global market, 2024 (%)
Key companies Pharma Sustained Release Agent sales in global market, 2020-2025 (estimated), (Kiloton)
Key companies Pharma Sustained Release Agent sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharma Sustained Release Agent, market overview.
Chapter 2: Global Pharma Sustained Release Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Pharma Sustained Release Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharma Sustained Release Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharma Sustained Release Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Pharma Sustained Release Agent Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Pharma Sustained Release Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharma Sustained Release Agent Overall Market Size
2.1 Global Pharma Sustained Release Agent Market Size: 2024 VS 2031
2.2 Global Pharma Sustained Release Agent Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Pharma Sustained Release Agent Sales: 2020-2031
3 Company Landscape
3.1 Top Pharma Sustained Release Agent Players in Global Market
3.2 Top Global Pharma Sustained Release Agent Companies Ranked by Revenue
3.3 Global Pharma Sustained Release Agent Revenue by Companies
3.4 Global Pharma Sustained Release Agent Sales by Companies
3.5 Global Pharma Sustained Release Agent Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Pharma Sustained Release Agent Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Pharma Sustained Release Agent Product Type
3.8 Tier 1, Tier 2, and Tier 3 Pharma Sustained Release Agent Players in Global Market
3.8.1 List of Global Tier 1 Pharma Sustained Release Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Pharma Sustained Release Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Pharma Sustained Release Agent Market Size Markets, 2024 & 2031
4.1.2 Gelatin
4.1.3 Polymers
4.1.4 Minerals
4.1.5 Sugars
4.1.6 Chitosan
4.2 Segment by Type - Global Pharma Sustained Release Agent Revenue & Forecasts
4.2.1 Segment by Type - Global Pharma Sustained Release Agent Revenue, 2020-2025
4.2.2 Segment by Type - Global Pharma Sustained Release Agent Revenue, 2026-2031
4.2.3 Segment by Type - Global Pharma Sustained Release Agent Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Pharma Sustained Release Agent Sales & Forecasts
4.3.1 Segment by Type - Global Pharma Sustained Release Agent Sales, 2020-2025
4.3.2 Segment by Type - Global Pharma Sustained Release Agent Sales, 2026-2031
4.3.3 Segment by Type - Global Pharma Sustained Release Agent Sales Market Share, 2020-2031
4.4 Segment by Type - Global Pharma Sustained Release Agent Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Pharma Sustained Release Agent Market Size, 2024 & 2031
5.1.2 Pharmaceutical
5.1.3 Health Care
5.1.4 Others
5.2 Segment by Application - Global Pharma Sustained Release Agent Revenue & Forecasts
5.2.1 Segment by Application - Global Pharma Sustained Release Agent Revenue, 2020-2025
5.2.2 Segment by Application - Global Pharma Sustained Release Agent Revenue, 2026-2031
5.2.3 Segment by Application - Global Pharma Sustained Release Agent Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Pharma Sustained Release Agent Sales & Forecasts
5.3.1 Segment by Application - Global Pharma Sustained Release Agent Sales, 2020-2025
5.3.2 Segment by Application - Global Pharma Sustained Release Agent Sales, 2026-2031
5.3.3 Segment by Application - Global Pharma Sustained Release Agent Sales Market Share, 2020-2031
5.4 Segment by Application - Global Pharma Sustained Release Agent Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Pharma Sustained Release Agent Market Size, 2024 & 2031
6.2 By Region - Global Pharma Sustained Release Agent Revenue & Forecasts
6.2.1 By Region - Global Pharma Sustained Release Agent Revenue, 2020-2025
6.2.2 By Region - Global Pharma Sustained Release Agent Revenue, 2026-2031
6.2.3 By Region - Global Pharma Sustained Release Agent Revenue Market Share, 2020-2031
6.3 By Region - Global Pharma Sustained Release Agent Sales & Forecasts
6.3.1 By Region - Global Pharma Sustained Release Agent Sales, 2020-2025
6.3.2 By Region - Global Pharma Sustained Release Agent Sales, 2026-2031
6.3.3 By Region - Global Pharma Sustained Release Agent Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Pharma Sustained Release Agent Revenue, 2020-2031
6.4.2 By Country - North America Pharma Sustained Release Agent Sales, 2020-2031
6.4.3 United States Pharma Sustained Release Agent Market Size, 2020-2031
6.4.4 Canada Pharma Sustained Release Agent Market Size, 2020-2031
6.4.5 Mexico Pharma Sustained Release Agent Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Pharma Sustained Release Agent Revenue, 2020-2031
6.5.2 By Country - Europe Pharma Sustained Release Agent Sales, 2020-2031
6.5.3 Germany Pharma Sustained Release Agent Market Size, 2020-2031
6.5.4 France Pharma Sustained Release Agent Market Size, 2020-2031
6.5.5 U.K. Pharma Sustained Release Agent Market Size, 2020-2031
6.5.6 Italy Pharma Sustained Release Agent Market Size, 2020-2031
6.5.7 Russia Pharma Sustained Release Agent Market Size, 2020-2031
6.5.8 Nordic Countries Pharma Sustained Release Agent Market Size, 2020-2031
6.5.9 Benelux Pharma Sustained Release Agent Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Pharma Sustained Release Agent Revenue, 2020-2031
6.6.2 By Region - Asia Pharma Sustained Release Agent Sales, 2020-2031
6.6.3 China Pharma Sustained Release Agent Market Size, 2020-2031
6.6.4 Japan Pharma Sustained Release Agent Market Size, 2020-2031
6.6.5 South Korea Pharma Sustained Release Agent Market Size, 2020-2031
6.6.6 Southeast Asia Pharma Sustained Release Agent Market Size, 2020-2031
6.6.7 India Pharma Sustained Release Agent Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Pharma Sustained Release Agent Revenue, 2020-2031
6.7.2 By Country - South America Pharma Sustained Release Agent Sales, 2020-2031
6.7.3 Brazil Pharma Sustained Release Agent Market Size, 2020-2031
6.7.4 Argentina Pharma Sustained Release Agent Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pharma Sustained Release Agent Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Pharma Sustained Release Agent Sales, 2020-2031
6.8.3 Turkey Pharma Sustained Release Agent Market Size, 2020-2031
6.8.4 Israel Pharma Sustained Release Agent Market Size, 2020-2031
6.8.5 Saudi Arabia Pharma Sustained Release Agent Market Size, 2020-2031
6.8.6 UAE Pharma Sustained Release Agent Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Teva Pharmaceutical Industries
7.1.1 Teva Pharmaceutical Industries Company Summary
7.1.2 Teva Pharmaceutical Industries Business Overview
7.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Agent Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.1.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.2 Mylan N.V.
7.2.1 Mylan N.V. Company Summary
7.2.2 Mylan N.V. Business Overview
7.2.3 Mylan N.V. Pharma Sustained Release Agent Major Product Offerings
7.2.4 Mylan N.V. Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.2.5 Mylan N.V. Key News & Latest Developments
7.3 Valeant Pharmaceuticals International
7.3.1 Valeant Pharmaceuticals International Company Summary
7.3.2 Valeant Pharmaceuticals International Business Overview
7.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Agent Major Product Offerings
7.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.3.5 Valeant Pharmaceuticals International Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Pharma Sustained Release Agent Major Product Offerings
7.4.4 Pfizer Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.4.5 Pfizer Key News & Latest Developments
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Company Summary
7.5.2 Sun Pharmaceutical Industries Business Overview
7.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Agent Major Product Offerings
7.5.4 Sun Pharmaceutical Industries Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.5.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Pharma Sustained Release Agent Major Product Offerings
7.6.4 Novartis AG Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.6.5 Novartis AG Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Pharma Sustained Release Agent Major Product Offerings
7.7.4 AstraZeneca Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Pharma Sustained Release Agent Major Product Offerings
7.8.4 GlaxoSmithKline Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Allergan
7.9.1 Allergan Company Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Pharma Sustained Release Agent Major Product Offerings
7.9.4 Allergan Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.9.5 Allergan Key News & Latest Developments
7.10 Janssen Pharmaceuticals
7.10.1 Janssen Pharmaceuticals Company Summary
7.10.2 Janssen Pharmaceuticals Business Overview
7.10.3 Janssen Pharmaceuticals Pharma Sustained Release Agent Major Product Offerings
7.10.4 Janssen Pharmaceuticals Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.10.5 Janssen Pharmaceuticals Key News & Latest Developments
7.11 Mayne Pharma Group
7.11.1 Mayne Pharma Group Company Summary
7.11.2 Mayne Pharma Group Business Overview
7.11.3 Mayne Pharma Group Pharma Sustained Release Agent Major Product Offerings
7.11.4 Mayne Pharma Group Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.11.5 Mayne Pharma Group Key News & Latest Developments
7.12 BASF
7.12.1 BASF Company Summary
7.12.2 BASF Business Overview
7.12.3 BASF Pharma Sustained Release Agent Major Product Offerings
7.12.4 BASF Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.12.5 BASF Key News & Latest Developments
7.13 International Flavors & Fragrances
7.13.1 International Flavors & Fragrances Company Summary
7.13.2 International Flavors & Fragrances Business Overview
7.13.3 International Flavors & Fragrances Pharma Sustained Release Agent Major Product Offerings
7.13.4 International Flavors & Fragrances Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.13.5 International Flavors & Fragrances Key News & Latest Developments
7.14 Ashland Global
7.14.1 Ashland Global Company Summary
7.14.2 Ashland Global Business Overview
7.14.3 Ashland Global Pharma Sustained Release Agent Major Product Offerings
7.14.4 Ashland Global Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.14.5 Ashland Global Key News & Latest Developments
7.15 Evonik Industries
7.15.1 Evonik Industries Company Summary
7.15.2 Evonik Industries Business Overview
7.15.3 Evonik Industries Pharma Sustained Release Agent Major Product Offerings
7.15.4 Evonik Industries Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.15.5 Evonik Industries Key News & Latest Developments
7.16 Croda International
7.16.1 Croda International Company Summary
7.16.2 Croda International Business Overview
7.16.3 Croda International Pharma Sustained Release Agent Major Product Offerings
7.16.4 Croda International Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.16.5 Croda International Key News & Latest Developments
7.17 Gattefosse
7.17.1 Gattefosse Company Summary
7.17.2 Gattefosse Business Overview
7.17.3 Gattefosse Pharma Sustained Release Agent Major Product Offerings
7.17.4 Gattefosse Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.17.5 Gattefosse Key News & Latest Developments
7.18 Merck KGaA
7.18.1 Merck KGaA Company Summary
7.18.2 Merck KGaA Business Overview
7.18.3 Merck KGaA Pharma Sustained Release Agent Major Product Offerings
7.18.4 Merck KGaA Pharma Sustained Release Agent Sales and Revenue in Global (2020-2025)
7.18.5 Merck KGaA Key News & Latest Developments
8 Global Pharma Sustained Release Agent Production Capacity, Analysis
8.1 Global Pharma Sustained Release Agent Production Capacity, 2020-2031
8.2 Pharma Sustained Release Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharma Sustained Release Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pharma Sustained Release Agent Supply Chain Analysis
10.1 Pharma Sustained Release Agent Industry Value Chain
10.2 Pharma Sustained Release Agent Upstream Market
10.3 Pharma Sustained Release Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pharma Sustained Release Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pharma Sustained Release Agent in Global Market
Table 2. Top Pharma Sustained Release Agent Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Pharma Sustained Release Agent Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Pharma Sustained Release Agent Revenue Share by Companies, 2020-2025
Table 5. Global Pharma Sustained Release Agent Sales by Companies, (Kiloton), 2020-2025
Table 6. Global Pharma Sustained Release Agent Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Pharma Sustained Release Agent Price (2020-2025) & (US$/Ton)
Table 8. Global Manufacturers Pharma Sustained Release Agent Product Type
Table 9. List of Global Tier 1 Pharma Sustained Release Agent Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharma Sustained Release Agent Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Pharma Sustained Release Agent Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Pharma Sustained Release Agent Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Pharma Sustained Release Agent Sales (Kiloton), 2020-2025
Table 15. Segment by Type - Global Pharma Sustained Release Agent Sales (Kiloton), 2026-2031
Table 16. Segment by Application – Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Pharma Sustained Release Agent Sales, (Kiloton), 2020-2025
Table 20. Segment by Application - Global Pharma Sustained Release Agent Sales, (Kiloton), 2026-2031
Table 21. By Region – Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Pharma Sustained Release Agent Sales, (Kiloton), 2020-2025
Table 25. By Region - Global Pharma Sustained Release Agent Sales, (Kiloton), 2026-2031
Table 26. By Country - North America Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Pharma Sustained Release Agent Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Pharma Sustained Release Agent Sales, (Kiloton), 2020-2025
Table 29. By Country - North America Pharma Sustained Release Agent Sales, (Kiloton), 2026-2031
Table 30. By Country - Europe Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Pharma Sustained Release Agent Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Pharma Sustained Release Agent Sales, (Kiloton), 2020-2025
Table 33. By Country - Europe Pharma Sustained Release Agent Sales, (Kiloton), 2026-2031
Table 34. By Region - Asia Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Pharma Sustained Release Agent Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Pharma Sustained Release Agent Sales, (Kiloton), 2020-2025
Table 37. By Region - Asia Pharma Sustained Release Agent Sales, (Kiloton), 2026-2031
Table 38. By Country - South America Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Pharma Sustained Release Agent Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Pharma Sustained Release Agent Sales, (Kiloton), 2020-2025
Table 41. By Country - South America Pharma Sustained Release Agent Sales, (Kiloton), 2026-2031
Table 42. By Country - Middle East & Africa Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Pharma Sustained Release Agent Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Pharma Sustained Release Agent Sales, (Kiloton), 2020-2025
Table 45. By Country - Middle East & Africa Pharma Sustained Release Agent Sales, (Kiloton), 2026-2031
Table 46. Teva Pharmaceutical Industries Company Summary
Table 47. Teva Pharmaceutical Industries Pharma Sustained Release Agent Product Offerings
Table 48. Teva Pharmaceutical Industries Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 49. Teva Pharmaceutical Industries Key News & Latest Developments
Table 50. Mylan N.V. Company Summary
Table 51. Mylan N.V. Pharma Sustained Release Agent Product Offerings
Table 52. Mylan N.V. Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 53. Mylan N.V. Key News & Latest Developments
Table 54. Valeant Pharmaceuticals International Company Summary
Table 55. Valeant Pharmaceuticals International Pharma Sustained Release Agent Product Offerings
Table 56. Valeant Pharmaceuticals International Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 57. Valeant Pharmaceuticals International Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Pharma Sustained Release Agent Product Offerings
Table 60. Pfizer Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 61. Pfizer Key News & Latest Developments
Table 62. Sun Pharmaceutical Industries Company Summary
Table 63. Sun Pharmaceutical Industries Pharma Sustained Release Agent Product Offerings
Table 64. Sun Pharmaceutical Industries Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 65. Sun Pharmaceutical Industries Key News & Latest Developments
Table 66. Novartis AG Company Summary
Table 67. Novartis AG Pharma Sustained Release Agent Product Offerings
Table 68. Novartis AG Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 69. Novartis AG Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Pharma Sustained Release Agent Product Offerings
Table 72. AstraZeneca Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline Pharma Sustained Release Agent Product Offerings
Table 76. GlaxoSmithKline Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. Allergan Company Summary
Table 79. Allergan Pharma Sustained Release Agent Product Offerings
Table 80. Allergan Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 81. Allergan Key News & Latest Developments
Table 82. Janssen Pharmaceuticals Company Summary
Table 83. Janssen Pharmaceuticals Pharma Sustained Release Agent Product Offerings
Table 84. Janssen Pharmaceuticals Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 85. Janssen Pharmaceuticals Key News & Latest Developments
Table 86. Mayne Pharma Group Company Summary
Table 87. Mayne Pharma Group Pharma Sustained Release Agent Product Offerings
Table 88. Mayne Pharma Group Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 89. Mayne Pharma Group Key News & Latest Developments
Table 90. BASF Company Summary
Table 91. BASF Pharma Sustained Release Agent Product Offerings
Table 92. BASF Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 93. BASF Key News & Latest Developments
Table 94. International Flavors & Fragrances Company Summary
Table 95. International Flavors & Fragrances Pharma Sustained Release Agent Product Offerings
Table 96. International Flavors & Fragrances Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 97. International Flavors & Fragrances Key News & Latest Developments
Table 98. Ashland Global Company Summary
Table 99. Ashland Global Pharma Sustained Release Agent Product Offerings
Table 100. Ashland Global Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 101. Ashland Global Key News & Latest Developments
Table 102. Evonik Industries Company Summary
Table 103. Evonik Industries Pharma Sustained Release Agent Product Offerings
Table 104. Evonik Industries Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 105. Evonik Industries Key News & Latest Developments
Table 106. Croda International Company Summary
Table 107. Croda International Pharma Sustained Release Agent Product Offerings
Table 108. Croda International Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 109. Croda International Key News & Latest Developments
Table 110. Gattefosse Company Summary
Table 111. Gattefosse Pharma Sustained Release Agent Product Offerings
Table 112. Gattefosse Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 113. Gattefosse Key News & Latest Developments
Table 114. Merck KGaA Company Summary
Table 115. Merck KGaA Pharma Sustained Release Agent Product Offerings
Table 116. Merck KGaA Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 117. Merck KGaA Key News & Latest Developments
Table 118. Pharma Sustained Release Agent Capacity of Key Manufacturers in Global Market, 2023-2025 (Kiloton)
Table 119. Global Pharma Sustained Release Agent Capacity Market Share of Key Manufacturers, 2023-2025
Table 120. Global Pharma Sustained Release Agent Production by Region, 2020-2025 (Kiloton)
Table 121. Global Pharma Sustained Release Agent Production by Region, 2026-2031 (Kiloton)
Table 122. Pharma Sustained Release Agent Market Opportunities & Trends in Global Market
Table 123. Pharma Sustained Release Agent Market Drivers in Global Market
Table 124. Pharma Sustained Release Agent Market Restraints in Global Market
Table 125. Pharma Sustained Release Agent Raw Materials
Table 126. Pharma Sustained Release Agent Raw Materials Suppliers in Global Market
Table 127. Typical Pharma Sustained Release Agent Downstream
Table 128. Pharma Sustained Release Agent Downstream Clients in Global Market
Table 129. Pharma Sustained Release Agent Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pharma Sustained Release Agent Product Picture
Figure 2. Pharma Sustained Release Agent Segment by Type in 2024
Figure 3. Pharma Sustained Release Agent Segment by Application in 2024
Figure 4. Global Pharma Sustained Release Agent Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Pharma Sustained Release Agent Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Pharma Sustained Release Agent Revenue: 2020-2031 (US$, Mn)
Figure 8. Pharma Sustained Release Agent Sales in Global Market: 2020-2031 (Kiloton)
Figure 9. The Top 3 and 5 Players Market Share by Pharma Sustained Release Agent Revenue in 2024
Figure 10. Segment by Type – Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Pharma Sustained Release Agent Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Pharma Sustained Release Agent Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Pharma Sustained Release Agent Price (US$/Ton), 2020-2031
Figure 14. Segment by Application – Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Pharma Sustained Release Agent Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Pharma Sustained Release Agent Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Pharma Sustained Release Agent Price (US$/Ton), 2020-2031
Figure 18. By Region – Global Pharma Sustained Release Agent Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Pharma Sustained Release Agent Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Pharma Sustained Release Agent Revenue Market Share, 2020-2031
Figure 21. By Region - Global Pharma Sustained Release Agent Sales Market Share, 2020-2031
Figure 22. By Country - North America Pharma Sustained Release Agent Revenue Market Share, 2020-2031
Figure 23. By Country - North America Pharma Sustained Release Agent Sales Market Share, 2020-2031
Figure 24. United States Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Pharma Sustained Release Agent Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Pharma Sustained Release Agent Sales Market Share, 2020-2031
Figure 29. Germany Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 30. France Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Pharma Sustained Release Agent Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Pharma Sustained Release Agent Sales Market Share, 2020-2031
Figure 38. China Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 42. India Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Pharma Sustained Release Agent Revenue Market Share, 2020-2031
Figure 44. By Country - South America Pharma Sustained Release Agent Sales, Market Share, 2020-2031
Figure 45. Brazil Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Pharma Sustained Release Agent Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Pharma Sustained Release Agent Sales, Market Share, 2020-2031
Figure 49. Turkey Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Pharma Sustained Release Agent Revenue, (US$, Mn), 2020-2031
Figure 53. Global Pharma Sustained Release Agent Production Capacity (Kiloton), 2020-2031
Figure 54. The Percentage of Production Pharma Sustained Release Agent by Region, 2024 VS 2031
Figure 55. Pharma Sustained Release Agent Industry Value Chain
Figure 56. Marketing Channels
